Semaglutide, the active ingredient in Novo Nordisks blockbuster diabetes and weight-loss medications Ozempic and Wegovy, has been on the FDAs shortage list since March 2022
Is medication the only answer
By acting on both the homeostatic (hunger-driven) and hedonic (pleasure-driven) aspects of eating, GLP-1 effectively recalibrates the brains perception of food
SeekPeptides provides members with monitoring tools and tracking guidance specifically designed for GLP-1 users, making it easy to know whether your nutrition supports your weight loss goals or is quietly sabotaging them

Research has examined its role in: GH secretion stimulation via selective GHS-R1a agonism IGF-1 axis modulation and downstream anabolic signalling research Longitudinal bone growth and bone mineral content investigations Body composition and lean tissue research in pre-clinical models Comparative GHRP selectivity and receptor-binding studies Postoperative gastrointestinal motility research via ghrelin receptor pathways Synergistic GH axis research when combined with GHRH analogues such as CJC-1295 Ipamorelin and Longitudinal Bone Growth Research In adult female rats administered Ipamorelin subcutaneously three times daily for 15 days, a dose-dependent increase in longitudinal bone growth rate was observed rising from 42 m/day in the vehicle group to 52 m/day at the highest dose confirming GH-mediated effects on skeletal tissue in pre-clinical models
The effect of (L-) carnitine on weight loss in adults: A systematic review and meta-analysis of randomized controlled trials